A 24-week, double-blind, placebo-control
β
Vee. P. Prasher; Adam Huxley; M. S. Haque
π
Article
π
2002
π
John Wiley and Sons
π
English
β 163 KB
π 1 views
## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This